Literature DB >> 3346249

The effect of nonenzymatic glucosylation on the binding of the main noncollagenous NC1 domain to type IV collagen.

E C Tsilibary1, A S Charonis, L A Reger, R M Wohlhueter, L T Furcht.   

Abstract

Type IV collagen has the ability to self-assemble by amino end, carboxyl end, and lateral associations to complex network-like structures which can be visualized by rotary shadowing. The main noncollagenous NC1 domain which is located at the carboxyl end of type IV collagen molecules binds to itself to form dimers and also binds along the length of type IV collagen. The latter binding initiates lateral assembly. Following in vitro nonenzymatic glucosylation of the isolated NC1 domain, binding to the helix-rich domain of type IV collagen was impaired. In turbidity experiments, the nonenzymatically glucosylated NC1 domain minimally suppressed the development of turbidity of collagen solutions when compared to control NC1 domain. In rotary shadowing experiments nonenzymatically glucosylated NC1 domain did not significantly inhibit lateral associations or networks formed by type IV collagen, whereas control NC1 domain caused a drastic decrease in laterally assembled structures. These data suggest that nonenzymatic glucosylation of the NC1 domain may interfere with normal assembly of type IV collagen in diabetes mellitus and may be related to abnormal functions of basement membranes in this pathological condition.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3346249

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

1.  Non-enzymatic glycation of type I collagen diminishes collagen-proteoglycan binding and weakens cell adhesion.

Authors:  Kristin L Reigle; Gloria Di Lullo; Kevin R Turner; Jerold A Last; Inna Chervoneva; David E Birk; James L Funderburgh; Elizabeth Elrod; Markus W Germann; Charles Surber; Ralph D Sanderson; James D San Antonio
Journal:  J Cell Biochem       Date:  2008-08-01       Impact factor: 4.429

2.  Studies on advanced glycation end products by recent mass spectrometric techniques.

Authors:  A Lapolla; D Fedele; P Traldi
Journal:  Amino Acids       Date:  1994-02       Impact factor: 3.520

Review 3.  Tissue elasticity and the ageing elastic fibre.

Authors:  Michael J Sherratt
Journal:  Age (Dordr)       Date:  2009-12

4.  Biochemical alterations in collagen IV induced by in vitro glycation.

Authors:  H M Raabe; H Molsen; S M Mlinaric; Y Açil; G H Sinnecker; H Notbohm; K Kruse; P K Müller
Journal:  Biochem J       Date:  1996-11-01       Impact factor: 3.857

Review 5.  The role of glycation in the pathogenesis of diabetic polyneuropathy.

Authors:  R H King
Journal:  Mol Pathol       Date:  2001-12

6.  Serum carboxymethyl-lysine, an advanced glycation end product, is associated with arterial stiffness in older adults.

Authors:  Richard D Semba; Kai Sun; Ann V Schwartz; Ravi Varadhan; Tamara B Harris; Suzanne Satterfield; Melissa Garcia; Luigi Ferrucci; Anne B Newman
Journal:  J Hypertens       Date:  2015-04       Impact factor: 4.844

7.  Increased collagen-linked pentosidine levels and advanced glycosylation end products in early diabetic nephropathy.

Authors:  P J Beisswenger; L L Moore; T Brinck-Johnsen; T J Curphey
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

8.  Inhibition of matrix-induced bone differentiation by advanced glycation end-products in rats.

Authors:  Y Fong; D Edelstein; E A Wang; M Brownlee
Journal:  Diabetologia       Date:  1993-09       Impact factor: 10.122

Review 9.  An intracellular trafficking pathway in the seminiferous epithelium regulating spermatogenesis: a biochemical and molecular perspective.

Authors:  C Yan Cheng; Dolores D Mruk
Journal:  Crit Rev Biochem Mol Biol       Date:  2009 Sep-Oct       Impact factor: 8.250

10.  Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy.

Authors:  H P Hammes; S Martin; K Federlin; K Geisen; M Brownlee
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.